Heywood Jablowme
Registered
Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage
Published Fri, Feb 21 2025, 12:56 PM EST
In other news, my research for
vendors intensifies...
Published Fri, Feb 21 2025, 12:56 PM EST
- The FDA said the shortage of semaglutide injection products such as Novo Nordisk’s Ozempic and Wegovy has been resolved.
- The agency said it will start taking action against compounders, which are allowed to produce custom-made alternatives to brand-name drugs during shortages, for violations in the next 60 to 90 days.
- The FDA said Friday that it will start taking action against compounders for violations in the next 60 to 90 days, depending on the type of facility, in order to “avoid unnecessary disruption to patient treatment.”
In other news, my research for
